According to Novocure 's latest financial reports the company's current earnings (TTM) are -$0.19 B. In 2022 the company made an earning of -$78.52 M a decrease over its 2021 earnings that were of -$48.64 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.19 B | 139.99% |
2022 | -$78.52 M | 61.43% |
2021 | -$48.64 M | -255.64% |
2020 | $31.24 M | 538.52% |
2019 | $4.89 M | -115.08% |
2018 | -$32.46 M | -15.13% |
2017 | -$38.24 M | -66.9% |
2016 | -$0.12 B | 10.26% |
2015 | -$0.11 B |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Organovo ONVO | -$19.09 M | -89.87% | ๐บ๐ธ USA |
Orchard Therapeutics
ORTX | -$73.07 M | -61.22% | ๐ฌ๐ง UK |
Novavax NVAX | -$0.53 B | 180.55% | ๐บ๐ธ USA |
Novocure
NVCR | -$0.19 B | 0.00% | Jersey |